Dataset
Nevirapine; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
Chemical Information
| InChI | InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20) |
|---|---|
| SMILES | CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4 |
| InChI Key | NQDJXKOVJZTUJA-UHFFFAOYSA-N |
| Molecular Formula | C15H14N4O |
| Exact Mass | 266.117 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-sa/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ01149803 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2024-05-08 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 4463 | PubChem |
| 60032853 | NMRShiftDB |
| PD000851 | ProbesDrugs |
| 63613 | ChEBI |
| 99DK7FVK1H | FDA SRS |
| 14872507 | PubChem: Thomson Pharma |
| 129618-40-2 | ACToR |
| SCHEMBL3318 | SureChEMBL |
| PA450616 | PharmGKB |
| Nevirapine(Viramune) | Selleck |
| LSM-5336 | LINCS |
| 766252 | eMolecules |
| CB9743074 | ChemicalBook |
| nevirapine | DailyMed |
| HMDB0014383 | Human Metabolome Database |
| 1896 | Brenda |
| MCULE-8608154492 | Mcule |
| SAM001246551 | NIH Clinical Collection |
| NVP | PDBe |
| 12014582 | PubChem: Drugs of the Future |
| C07263 | KEGG Ligand |
| DB00238 | DrugBank |
| CHEMBL57 | ChEMBL |
| 1904 | DrugCentral |
| ZINC000000004778 | ZINC |
| DTXSID7031797 | EPA CompTox Dashboard |
| HY-10570 | MedChemExpress |
| BIRG-0587 | clinicaltrials |
| BIRG 0587 | clinicaltrials |
| VIRAMUNE | clinicaltrials |
| NEVIRAPINE | clinicaltrials |
| VIRAMUNE | rxnorm |
| NEVIRAPINE | rxnorm |
| NEVIRAPINE | DailyMed |
| PABHIJ | CCDC |
| J420.601K | Nikkaji |
| 1434 | BindingDB |
| The data in this table is sourced from UniChem at EBI. | |